COPPOLA, ANTONIETTA
 Distribuzione geografica
Continente #
AS - Asia 4.026
NA - Nord America 2.677
EU - Europa 2.561
SA - Sud America 685
AF - Africa 103
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.059
Nazione #
US - Stati Uniti d'America 2.515
SG - Singapore 2.252
RU - Federazione Russa 1.488
CN - Cina 796
BR - Brasile 573
HK - Hong Kong 407
IT - Italia 388
VN - Vietnam 316
DE - Germania 175
CA - Canada 96
NL - Olanda 85
FI - Finlandia 69
GB - Regno Unito 69
SE - Svezia 53
FR - Francia 49
AR - Argentina 48
IN - India 43
UA - Ucraina 42
KR - Corea 41
MX - Messico 37
AT - Austria 35
ZA - Sudafrica 32
BD - Bangladesh 31
IE - Irlanda 28
CI - Costa d'Avorio 24
PL - Polonia 24
ID - Indonesia 23
IQ - Iraq 18
TR - Turchia 17
JP - Giappone 16
EC - Ecuador 15
CL - Cile 12
MA - Marocco 10
PE - Perù 8
TN - Tunisia 8
UY - Uruguay 8
BE - Belgio 7
CO - Colombia 7
ES - Italia 7
LT - Lituania 7
PK - Pakistan 7
PY - Paraguay 7
IR - Iran 6
JO - Giordania 6
UZ - Uzbekistan 6
NO - Norvegia 5
VE - Venezuela 5
AL - Albania 4
AZ - Azerbaigian 4
DZ - Algeria 4
GT - Guatemala 4
HN - Honduras 4
KE - Kenya 4
KZ - Kazakistan 4
NI - Nicaragua 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
AO - Angola 3
BH - Bahrain 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EG - Egitto 3
KG - Kirghizistan 3
MK - Macedonia 3
MN - Mongolia 3
PH - Filippine 3
PR - Porto Rico 3
AF - Afghanistan, Repubblica islamica di 2
AU - Australia 2
BB - Barbados 2
BW - Botswana 2
BY - Bielorussia 2
CU - Cuba 2
CV - Capo Verde 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
ME - Montenegro 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
RW - Ruanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TL - Timor Orientale 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GF - Guiana Francese 1
Totale 10.040
Città #
Singapore 995
Hong Kong 406
Moscow 327
Chandler 260
Hefei 223
Beijing 209
Ashburn 189
Santa Clara 179
Boston 100
Ho Chi Minh City 100
Los Angeles 98
Millbury 93
Naples 82
Des Moines 79
Princeton 78
Amsterdam 73
Nanjing 70
Redondo Beach 63
Ottawa 61
São Paulo 53
Buffalo 52
Hanoi 48
Napoli 46
Lawrence 45
Munich 43
Seoul 38
Nuremberg 37
The Dalles 36
New York 35
San Jose 35
Jacksonville 31
Seattle 29
Dong Ket 28
Milan 26
Norwalk 26
Shenyang 25
Dallas 23
Lappeenranta 23
Rio de Janeiro 23
Ann Arbor 21
Frankfurt am Main 21
Hebei 21
Jiaxing 21
Wilmington 21
Denver 20
Stockholm 19
Vienna 19
Chicago 16
Düsseldorf 16
Helsinki 16
London 16
Haiphong 15
Mexico City 14
Porto Alegre 14
Atlanta 13
Houston 13
Johannesburg 13
Nanchang 13
Tianjin 13
Curitiba 12
Orem 12
Warsaw 12
Woodbridge 12
Boardman 10
Castelnuovo Rangone 10
Chennai 10
Falkenstein 10
Poplar 10
Ankara 9
Belo Horizonte 9
Brasília 9
Brooklyn 9
Changsha 9
Dhaka 9
Fairfield 9
Hải Dương 9
Montreal 9
Tokyo 9
Caxias do Sul 8
Montevideo 8
Ninh Bình 8
Osasco 8
Salt Lake City 8
Vancouver 8
Baghdad 7
Nha Trang 7
Rome 7
Thái Bình 7
Thái Nguyên 7
Amman 6
Betim 6
Bologna 6
Can Tho 6
Florianópolis 6
Ha Long 6
Hangzhou 6
Jakarta 6
Kagoya 6
Lauterbourg 6
Manaus 6
Totale 5.059
Nome #
A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome). 132
A pilot open-label trial of zonisamide in Unverricht-Lundborg disease. 126
Diagnostic implications of genetic copy number variation in epilepsy plus 118
Diagnosis and management of type 1 sialidosis: Clinical insights from long-term care of four unrelated patients 116
An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. 113
Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study. 111
Inherited neuromyotonia: A clinical and genetic study of a family. 110
Clinical phenotype and molecular characterization of 6q terminal deletion syndrome: Five new cases. 109
Novel biallelic variants expand the phenotype of NAA20-related syndrome 108
Epileptic myoclonus as ciprofloxacin-associated adverse effect. 108
Xq25 microduplication syndrome: A further contribution to its definition. A case report and review of the literature 108
A de novo 11p12-p15.4 duplication in a patient with pharmacoresistant epilepsy, mental retardation, and dysmorphisms. 107
Intronic ATTTC repeat expansions in STARD7 in familial adult myoclonic epilepsy linked to chromosome 2 106
Dual diagnosis in a child with familial SCN8A-related encephalopathy complicated by a 1p13.2 deletion involving NRAS gene 105
Life-threatening status epilepticus following gabapentin administration in a patient with benign adult familial myoclonic epilepsy. 104
Bergmeister's papilla in a young patient with type 1 sialidosis: Case report 104
Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox-Gastaut Syndrome. 104
Alterations in the α2δ ligand, thrombospondin-1, in a rat model of spontaneous absence epilepsy and in patients with idiopathic/genetic generalized epilepsies 103
Sialidosis type 1: Long-term care of two unrelated patients and effectiveness of low doses of Perampanel 102
Dissecting genetics of spectrum of epilepsies with eyelid myoclonia by exome sequencing 102
The syndrome gelastic seizures-hypothalamic hamartoma: severe, potentially reversible encephalopathy. 102
Different electroclinical picture of generalized epilepsy in two families with 15q13.3 microdeletion. 102
GABAergic dysfunction mediates motor impairment in Rett syndrome 102
Familial mesial temporal lobe epilepsy (FMTLE) : a clinical and genetic study of 15 Italian families. 101
X-Linked Epilepsies: A Narrative Review 99
Temporal lobe malformations, focal epilepsy, and FGFR3 mutations: a non-causal association? 98
Clinical features and genotype–phenotype correlations in epilepsy patients with de novo DYNC1H1 variants 97
CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation 96
From cannabis to cannabidiol to treat epilepsy, where are we? 96
Genotype-phenotype correlations in patients with de novo KCNQ2 pathogenic variants 96
Unfavourable outcome of Hashimoto encephalopathy due to status epilepticus. One autopsy case. 95
Serum MHD monitoring may be useful in the management of side effects in epileptic patients on high doses of oxcarbazepine. 94
KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum. 94
Reflex seizures and reflex epilepsies: old models for understanding mechanisms of epileptogenesis. 92
Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsy 91
A pilot open-label trial of zonisamide inUnverricht-Lundborg disease. 91
Epilepsy in Rett syndrome: can seizures play an encephalopathic effect in this disorder? 91
Milder presentation of TELO2-related syndrome in two sisters homozygous for the p.Arg609His pathogenic variant 91
Neurophysiological Signatures of Motor Impairment in Patients with Rett Syndrome 90
Temporal-parietal-occipital epilepsy in GEFS+ associated with SCN1A mutation 90
An Italian consensus on the management of Lennox-Gastaut syndrome 89
Myoclonus: Differential diagnosis and current management 88
Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis 88
The occurrence of lateral shift in cervical dystonia 88
Clinical significance of rare copy number variations in epilepsy: a case-control survey using microarray-based comparative genomic hybridization. 87
Neurological features and long-term follow-up in 15q11.2-13.1 duplication. 87
Spectrum of epilepsy with eyelid myoclonia: Delineation of disease subtypes from a large multicenter study 86
Difficult-to-treat absences in a female patient with ornithin-transcarbamylase (OTC) deficit 86
Epilepsy Course and Developmental Trajectories in STXBP1 -DEE 85
Natural history and long-term evolution in families with autosomal dominant cortical tremor, myoclonus, and epilepsy. 85
Chewing induced reflex seizures (“eating epilepsy”) and eye closure sensitivity as a common feature in pediatric patients with SYNGAP1 mutations: Review of literature and report of 8 cases 85
Advances in genetic testing and optimization of clinical management in children and adults with epilepsy 85
Dramatic response to levetiracetam in post-ischaemic Holmes' tremor. 84
Rare coding variants in genes encoding GABAAreceptors in genetic generalised epilepsies: an exome-based case-control study 84
Hydranencephaly in CENPJ-related Seckel syndrome 83
Sex-based electroclinical differences and prognostic factors in epilepsy with eyelid myoclonia 82
Targeted re-sequencing in malformations of cortical development: genotype-phenotype correlations 82
Real-life survey of pitfalls and successes of precision medicine in genetic epilepsies. 82
Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study) 81
Epilepsy and mental retardation in a patient with 15q 24.1-25.1 interstitial deletion revealed by array-CGH 78
Characterization of a recurrent 15q24 microdeletion syndrome 78
Epilepsy, cerebral calcifications, and gluten-related disorders: Are anti-transglutaminase 6 antibodies the missing link? 78
Neuropsychological findings in patients with Unverricht-Lundborg disease. 77
Clinical efficacy of low-dose Perampanel correlates with neurophysiological changes in familial adult myoclonus epilepsy 2 76
Epilepsy, EEG and chromosomal rearrangements 74
Current treatment options for familial adult myoclonus epilepsy 74
Cortical and subcortical networks dysfunction in NEXMIF encephalopathy 73
Familial Adult Myoclonus Epilepsy: A Non-Coding Repeat Expansion Disorder of Cerebellar-Thalamic-Cortical Loop 71
Management of epilepsy in brain tumors 71
Abnormal sensorimotor cortex and thalamo-cortical networks in familial adult myoclonic epilepsy type 2: pathophysiology and diagnostic implications 71
De novo missense variants in the E3 ubiquitin ligase adaptor KLHL20 cause a developmental disorder with intellectual disability, epilepsy, and autism spectrum disorder 70
Epileptic myoclonus as ciprofloxacin-associated adverse effect [8] 67
Perampanel as precision therapy in rare genetic epilepsies 66
Familial adult myoclonus epilepsy: Clinical findings, disease course, and comorbidities 64
17q21.31 microdeletion syndrome: Description of a case further contributing to the delineation of Koolen-de Vries syndrome 64
CHD2 variants are a risk factor for photosensitivity in epilepsy 63
The spectrum of intermediate SCN8A-related epilepsy 63
Beneficial Effects of L-Arginine in Patients Hospitalized for COVID-19: New Insights from a Randomized Clinical Trial 61
Psychiatric comorbidities in patients from seven families with autosomal dominant cortical tremor, myoclonus, and epilepsy 61
Cortical tremor: a tantalizing conundrum between cortex and cerebellum 61
A solved puzzle: Familial adult myoclonus epilepsy is a new expansion repeats disorder 60
Endothelial extracellular vesicles enriched in microRNA-34a predict new-onset diabetes in COVID-19 patients: novel insights for long-COVID metabolic sequelae 60
TBCE Mutations Cause Early-Onset Progressive Encephalopathy with Distal Spinal Muscular Atrophy 59
6q terminal deletion: An emerging syndrome associated to a peculiar clinical and electroencephalographic picture 59
The impact of epilepsy on quality of life: Findings from a European survey 58
The impact of epilepsy and antiseizure medications on sleep: Findings from a large European survey in adults with epilepsy and matched controls 57
Electroclinical Features and Long-term Seizure Outcome in Patients With Eyelid Myoclonia With Absences 56
The challenges of treating epilepsy with 25 antiepileptic drugs 54
De novo SMARCA2 variants clustered outside the helicase domain cause a new recognizable syndrome with intellectual disability and blepharophimosis distinct from Nicolaides–Baraitser syndrome 54
Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies 54
Antiepileptic drugs under investigation for treatment of focal epilepsy 53
Photosensitive epilepsy is associated with reduced inhibition of alpha rhythm generating networks 53
High-functioning autism spectrum disorder with fluent speech and late-onset epilepsy: an unusual presentation of Inv-Dup (15) syndrome. 53
Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program 53
A clinical and genetic study of 33 new cases with early-onset absence epilepsy. 52
Italian report on RARE epilepsies (i‐RARE): A consensus on multidisciplinarity 50
Animal models 50
Antibiotics and de novo status epilepticus 50
Epilepsy in KAT6A syndrome: Description of two individuals and revision of the literature 50
Thalamic and cortical hyperexcitability in juvenile myoclonic epilepsy 49
Totale 8.266
Categoria #
all - tutte 35.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021112 0 0 0 0 0 0 22 4 19 24 14 29
2021/2022584 85 5 3 3 8 8 9 20 44 30 73 296
2022/2023677 128 53 16 30 74 78 0 64 89 73 45 27
2023/2024563 22 88 49 28 34 41 17 39 4 23 159 59
2024/20253.522 204 216 6 15 104 211 378 251 292 424 1.106 315
2025/20264.196 692 625 749 707 1.125 274 24 0 0 0 0 0
Totale 10.317